NovMetaHealth is a specialized new drug development company that researches and develops first-in-class drugs and high-functional health functional food. NovMetaHealth has secured original technologies such as Alzheimer’s disease, acute pancreatitis, liver cancer medication, and cytokine inhibitor, and is making active efforts in R&D domestically and internationally to commercialize them.
|Company Name||NovMetaHealth Co., Ltd.|
|Establishment||March 17th, 2016|
|Business Type||(M70113) Medication and pharmaceutical R&D|
|Main Products||Alzheimer’s disease, acute pancreatitis, liver cancer medication, and cytokine inhibitor|